AMERICAN VANGUARD CORP AVD

Healthcare SIC 2870 - Agricultural Chemicals NYSE

American Vanguard Corporation ("AVD") was incorporated under the laws of the State of Delaware in January 1969 and operates as a holding company. The Company conducts its business through its principal operating subsidiaries, including AMVAC Chemical Corporation ("AMVAC") for its domestic business and AMVAC Netherlands BV ("AMVAC BV") for its international business.

The operating subsidiaries in the U.S. include: AMVAC, GemChem, Inc. ("GemChem"), TyraTech Inc. ("TyraTech") and OHP Inc. ("OHP").

Internationally, the Company operates its business through the following subsidiaries: AMVAC BV, AMVAC Hong Kong Limited ("AMVAC Hong Kong"), AMVAC Mexico Sociedad de Responsabilidad Limitada ("AMVAC M"), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada ("AMVAC CR Srl"), Grupo AgriCenter (including the parent AgriCenter S.A. and its subsidiaries) ("AgriCenter"), AMVAC do Brasil Representácoes Ltda ("AMVAC do Brasil"), AMVAC do Brazil 3p LTDA ("AMVAC 3p"), American Vanguard Australia PTY Ltd ("AVD Australia"), AgNova Technologies PTY Ltd ("AgNova"), and the Agrinos group entities ("Agrinos").

Last close 2.33 2026-09-04
Market cap $68.7M 2026-06-30 share count
52-week range 2.02 - 5.92

Valuation FY2025 figures against the last close

P/S0.1x
P/E
P/FCF
EV/EBITDA
Dividend yield0.0%
Diluted EPS-1.75

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $515.1M$547.3M$579.4M$609.6M$557.7M$458.7M$468.2M$454.3M$355.0M$312.1M
Cost of revenue $367.6M$427.0M$400.2M$417.2M$387.0M$286.1M$290.8M$271.6M$207.7M$183.8M
Gross profit $147.6M$120.3M$179.2M$192.4M$170.7M$172.6M$177.4M$182.6M$147.4M$128.3M
R&D $23.2M$32.7M$38.0M$31.8M$28.9M$26.3M$24.1M$26.4M$26.1M$21.3M
SG&A $110.6M$119.6M$116.9M$119.9M$111.1M$36.1M$46.6M$43.0M$37.7M$32.1M
Total operating expenses $8.9M$10.9M$12.3M$10.8M$183.3M$154.3M$151.1M$143.6M$120.6M$107.7M
Operating income -$28.3M-$101.6M$23.3M$40.7M$30.9M$22.9M$26.2M$39.0M$26.8M$20.5M
Interest expense $18.5M$16.5M$12.6M$4.0M$3.7M$5.2M$7.2M$4.0M$1.9M$1.6M
Pre-tax income -$47.2M-$120.5M$10.3M$36.0M$27.1M$18.4M$19.0M$33.6M$24.9M$18.9M
Income tax $2.7M$5.9M$2.8M$8.6M$8.2M$3.1M$5.2M$9.1M$4.4M$5.5M
Net income -$49.9M-$124.9M$7.5M$27.4M$18.6M$15.2M$13.6M$24.2M$20.3M$12.8M
EPS, basic -1.75-4.500.270.940.620.520.470.830.700.44
EPS, diluted -1.75-4.500.260.920.610.510.460.810.680.44
Shares, diluted (wtd. avg.) $28.4M$28.1M$28.5M$29.9M$30.4M$30.0M$29.7M$30.0M$29.7M$29.4M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $20.3M$16.3M$15.9M$6.6M$6.2M$11.3M$7.9M
Receivables $160.5M$169.7M$182.6M$156.5M$149.3M$130.0M$136.1M$123.3M$102.5M$83.8M
Inventory $176.0M$179.3M$219.6M$184.2M$154.3M$163.8M$163.3M$159.9M$123.1M$120.6M
Total current assets $370.5M$378.9M$432.0M$388.6M$342.0M$330.2M$336.2M$310.2M$254.9M$227.1M
Property, plant and equipment $53.0M$58.2M$74.6M$70.9M$66.1M$65.4M$56.5M$49.3M$49.3M$50.3M
Goodwill $0$19.7M$51.2M$47.0M$46.3M$52.1M$46.7M$25.9M$22.3M
Other intangibles $138.7M$150.5M$172.5M$184.7M$197.8M$197.5M$198.3M$186.5M$180.8M$121.4M
Total assets $596.5M$636.7M$767.5M$726.3M$694.2M$680.3M$670.1M$593.6M$535.6M$430.0M
Accounts payable $87.5M$69.2M$68.8M$69.0M$67.1M$59.3M$64.9M$66.5M$53.7M$24.4M
Short-term debt $0
Total current liabilities $209.4M$232.3M$230.5M$266.6M$223.1M$171.3M$138.6M$145.5M$126.2M$97.1M
Long-term debt $174.0M$147.3M$138.9M$51.5M$52.2M$107.4M$148.8M$96.7M$77.5M$41.0M
Total liabilities $404.1M$403.6M$397.5M$356.3M$321.4M$319.6M$325.9M$264.4M$230.3M$147.6M
Retained earnings $155.0M$204.9M$332.9M$328.7M$304.4M$288.2M$274.1M$262.8M$239.0M$220.4M
Total equity $192.4M$233.1M$370.0M$370.0M$372.7M$360.7M$344.2M$329.2M$305.3M$282.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$21.2M$3.9M-$58.7M$57.1M$86.4M$90.3M$9.6M$11.7M$59.0M$46.4M
Depreciation and amortisation $5.3M$5.2M$6.6M$8.9M$9.2M$7.5M$6.5M$8.1M$8.2M$8.3M
Stock-based compensation $2.0M$4.4M$6.1M$5.7M$6.9M$6.6M$7.2M$5.8M$4.7M$3.2M
Capital expenditure $3.9M$7.3M$11.9M$13.3M$9.5M$11.2M$13.0M$8.1M$6.7M$10.6M
Investing cash flow -$3.6M-$6.6M-$17.0M-$14.5M-$20.0M-$35.8M-$54.8M-$28.0M-$89.5M-$14.1M
Financing cash flow $23.7M$4.5M$66.7M-$38.3M-$65.9M-$44.4M$46.4M$11.1M$33.9M-$28.5M
Dividends paid $0$2.5M$3.4M$2.8M$2.4M$1.2M$2.3M$2.2M$1.6M$578.0K
Buybacks $0$0$15.5M$34.0M$4.6M$0$2.6M$7.3M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-173620.

Others in SIC 2870

TickerCompanyMarket capP/ERevenue growth
CF CF Industries Holdings, Inc. $20.18B 14.9x 19.3%
MOS MOSAIC CO $8.22B 15.2x 8.4%
SMG SCOTTS MIRACLE-GRO CO $3.46B 24.1x -3.9%
UAN CVR PARTNERS, LP $1.38B 14.0x 15.4%
CBUS Cibus, Inc. $122.0M -14.6%
SNES SenesTech, Inc. $5.4M 19.6%
BIOX Bioceres Crop Solutions Corp. -27.9%
ICL ICL Group Ltd. 4.6%